Serum Levels of IGF-I, HGF, TGFβ1, bFGF and VEGF in Thyroid Gland Tumors

Physiological Research

Volumn 53, Issue 1, 2004, Pages 83-89

  Vesely D ^a   Astl, J ^a,b   Lastuvka P ^a   Matucha, P ^c   Sterzl I ^b,c   Betka, J ^a,b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Angiogenesis; Growth factors; Thyroid adenoma; Thyroid gland; Thyroid papillary carcinoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR CELL; TUMOR GROWTH;

ADENOMA; CARCINOMA, PAPILLARY; FEMALE; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOVASCULARIZATION, PATHOLOGIC; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542315945     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BACHRACH LK, LIU FR, BURROW GN, EGGO MC: Characterization of insulin like growth factor binding proteins from sheep thyroid cells. Endocrinology 125: 2831-2838, 1989.
2. BACHRACH LK, EGGO MC, BURROW GN, LIU FR, TRAM T, POWELL DR: Regulation of insulin like growth factor binding protein messenger ribonucleic acid levels in sheep thyroid cells. Endocrinology 128: 1967-1973, 1991.
3. BACHRACH LK, EGGO MC, HINTZ RL, BURROW GN: Insulin like growth factors in sheep thyroid cells: action, receptors and production. Biochem Biophys Res Commun 154: 861-867, 1988.
4. BECKS GP, LOGAN A, PHILLIPS ID, WANG JF, SMITH C, DESOUSA D, HILL DJ: Increase of basic fibroblast growth factor (FGF) and FGF receptor messenger RNA during rat thyroid hyperplasia: temporal changes and cellular distribution. J Endocrinol 142: 325-338, 1994.
5. BEERE HM, SODEN J, TOMLINSON S, BIDEY SP: Insulin like growth factor I production and action in porcine thyroid follicular cells in monolayer: regulation by transforming growth factor β. J Endocrinol 130: 3-9, 1991.
6. COWIN AJ, BIDEY SP: Transforming growth factor β1 synthesis in human thyroid follicular cells: differential effects of iodide and plasminogen on the production of latent and active peptide forms. J Endocrinol 141: 183-190, 1994.
7. COWIN AJ, BIDEY SP: Heterogeneity of transforming growth factor β1 (TGFβ1) synthesis, activation and responsiveness profiles in thyroid follicular cell cultures derived from human multinodular nontoxic goitres. J Endocrinol 151: 103, 1996.
8. COWIN AJ, HEATON EL, CHESHIRE SH, BIDEY SP: The proliferative responses of porcine thyroid follicular cells to epidermal growth factor and thyrotropin reflect the autocrine production of transforming growth factor β1 J Endocrinol 148: 87-94, 1996.
9. DREMIER S, TATON M, COULONVAL K, NAKAMURA T, MATSUMOTO K, DUMONT JE: Mitogenic, dedifferentiating and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 135: 135-140, 1994.
10. ECCLES N, IVAN M, WYNFORD-THOMAS D: Mitogenic stimulation of normal and oncogene transformed human thyroid epithelial cells by hepatocyte growth factor. Mol Cell Endocrinol 117: 247-251, 1996.
11. EGGO MC, BACHRACH LK, BURROW GN: Interaction of TSH, insulin and insulin like growth factors in regulating thyroid growth and function. Growth Factors 2: 99-109, 1990.
12. EGGO MC, HOPKINS JM, FRANKLYN JA, JOHNSON GD, SANDERS DS, SHEPPARD MC: Expression of fibroblast growth factors in thyroid cancer. J Clin Endocrinol Metab 80: 1006-1011, 1995.
13. EGGO MC, KING W, BLACK EG, SHEPPARD MC: Functional human thyroid cells and their insulin like growth factor binding proteins: regulation by thyrotropin, cyclic 3′5′-adenosine monophosphate and growth factors. J Clin Endocrinol Metab 81: 3056-3062, 1996.
14. FELLMER PT, SATO K, TANAKA R, OKAMOTO T, KATO Y, KOBAYASHI M, SHIBUYA M, OBARA T: Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 126: 1056-1062, 1999.
15. FRANZEN A, PIEK E, WESTERMARK B, TEN DIJKE P, HELDIN NE: Expression of transforming growth factor β1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 140: 4300-4310, 1999.
16. HRDÁ P, ŠTERZL I, MATUCHA P: Comparison of cytokine levels in sera of patients with autoimmune endocrinopaties. Physiol Res 52: 265-267, 2003.
17. KATOH R, MIYAGI E, KAWAOI A, HEMMI A, KOMIYAMA A, OYAMA T, SHIBUYA M: Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 30: 891-897, 1999.
18. KLENER P: Cytokines in Internal Medicine. (in Czech) Grada Publishing, Prague, 1997, pp 260.
19. PATEL VA, HILL DJ, EGGO MC, SHEPPARD MC, BECKS GP, LOGAN A: Changes in the immunohistochemical localisation of FGF-2, TGFβ1 and thrombospondin-1 are associated with the early angiogenic events in the hyperplastic rat thyroid. J Endocrinol 148: 185-199, 1996.
20. SATO K, YAMAZAKI K, SHIZUME K, KANAJI Y, OBARA T, OHSUMI K, DEMURA H, YAMAGUCHI S, SHIBUYA M: Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96: 1295-1302, 1995.
21. SATO K, MIYAKAWA M, ONODA N, DEMURA H, YAMASHITA T, MIURA M, KASAJIMA T, YAMAZAKI K, OBARA T: Increased concentrations of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules. J Clin Endocrinol Metab 82: 1968-1973, 1997.
22. SHINGU K, FUJIMORI M, ITO K, HAMA Y, KASUGA Y, KOBAYASHI S, ITOH N, AMANO J: Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions. Endocr J 45: 35-43, 1998.
23. ŠTERZL I: Cytokines - structure and function I., II. (in Czech) Diabetologie, metabolismus, endokrinologie, výživa 4: 185-205, 1999.
24. TROVATO M, VILLARI D, BARTOLONE L, SPINELLA S, SIMONE A, VIOLI MA, TRIMARCHI F, BATOLO D, BENVENGA S: Expression of the hepatocyte growth factor and c-met in normal thyroid, nonneoplastic, and neoplastic nodules. Thyroid 8: 125-131, 1998.
25. VIGLIETTO G, ROMANO A, MANZO G, CHIAPPETTA G, PAOLETTI I, CALIFANO D, GALATI MG, MAURIELLO V, BRUNI P, LAGO CT, FUSCO A, PERSICO MG: Upregulation of the angiogenic factor PIGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in the thyroid gland of thiouracil-fed rats suggests a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15: 2687-2698, 1997.
26. WANG JF, MILOSVESKI V, SCHRAMEK C, FONG GH, BECKS GP, HILL DJ: Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. J Endocrinol 157: 5-12, 1998.